Related Experiment Video
Updated: Sep 13, 2025

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Palliative management of type 2 diabetes mellitus in patients with advanced cancer
Taylan Gurgenci1, Phillip Good2, Jones Chen3
1FRACP, FAChPM, Palliative Care Specialist, St Vincent@s Private Hospital, Brisbane, Qld.
Background:
Patients with advanced cancer often have type 2 diabetes mellitus (T2DM) and are on multiple medications that affect glycaemic control. Patients can have pre‑existing diabetes or treatment- and glucocorticoid-induced hyperglycaemia. Optimal management of glycaemic control differs at varying stages of life and depends on overall goals of care.
Objective:
This article summarises the evidence-based management of T2DM in patients with advanced cancer, including management of glucocorticoid-induced hyperglycaemia, and appropriate targets for glycated haemoglobin (HbA1c).
Discussion:
T2DM often co-exists in patients with advanced cancer. Management is aimed at reducing the complications of hyperglycaemia and hypoglycaemia, and maximising quality of life. Interventions and treatments need to be balanced against quality of life and prognosis.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Chronic Pancreatitis II: Collaborative Care
Assessment:
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Peripheral Artery Disease IV: Nursing Management

